Search
Integra Lifesciences Holdings Corp
IARTAdd to Watchlist
18.050USD
+0.160+0.89%
Close 07/02, 13:00（ET）Quotes delayed by 15 min
1.41BMarket Cap
LossP/E TTM
View Detailed Chart
TradingKey 图表Intraday
1m
30m
1h
D
W
M
D
Today
+0.89%
5 Days
-3.78%
1 Month
+2.79%
6 Months
+50.29%
Year to Date
+45.33%
1 Year
+33.80%
Key Figures
18.060Open
18.340High
683.03KVolume
LossP/E TTM
6.93P/E Dynamic
--Dividend TTM
0.88%Turnover Ratio
17.890Prev. Close
17.760Low
9.67MTurnover
LossP/E Static
1.35P/B
0.00%Div Yield TTM
-13.00%ROA
16.62052wk High
1.03Volume Ratio
-6.94MNet Profit
77.89MShares
-6.4654EPS TTM
1.23Beta
-38.64%ROE
8.70052wk Low
3.24%Amplitude
57.18%Gross Margin
1.41BMarket Cap
0.56Reward/Risk
3.38%Risk Rate
TradingKey Stock Score of Integra Lifesciences Holdings Corp
Currency: USD Updated: 2026-07-02Key Insights
Integra Lifesciences Holdings Corp's fundamentals are relatively stable, and its growth potential is high.Its valuation is considered fairly valued, ranking 73 out of 204 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Hold, with the highest price target at 17.20.In the medium term, the stock price is expected to trend up.Despite an average stock market performance over the past month, the company shows strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Integra Lifesciences Holdings Corp's Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Media Coverage
Last 24 hours
Coverage Level
Very Low
Very High
Neutral
Integra Lifesciences Holdings Corp Highlights
StrengthsRisks
Integra LifeSciences Holdings Corporation is a global medical technology company. The Company manufactures and sells medical technologies and products in two segments: Codman Specialty Surgical (CSS) and Tissue Technologies (TT). The CSS segment consists of technologies and instrumentation used for a range of specialties, such as neurosurgery, neurocritical care and otolaryngology. The CSS business consists of a portfolio of brands, such as Codman, DuraGen, DuraSeal, CUSA, Mayfield, Bactiseal, and Certas Plus, which are used for the management of multiple disease states, including brain tumors, traumatic brain injury, hydrocephalus and other neurological conditions. It provides instruments that are used in precision, specialty and general surgical procedures. The TT segment is focused on three main areas: complex wound surgery, surgical reconstruction and peripheral nerve repair. The TT segment offers skin and wound repair, plastics and surgical reconstruction products, and others.
Undervalued
The company’s latest PE is -2.79, at a low 3-year percentile range.
Institutional Selling
The latest institutional holdings are 82.80M shares, decreasing 14.91% quarter-over-quarter.
Held by Chuck Royce
Star Investor Chuck Royce holds 2.53K shares of this stock.
Analyst Rating
Based on
10
analysts
Hold
Current Rating
17.200
Target Price
-3.86%
Upside Space
Integra Lifesciences Holdings Corp News
More news coming soon, stay tuned...
Financial Indicators
EPS
Relevant data have not been disclosed by the company yet.
Total revenue
Relevant data have not been disclosed by the company yet.
Integra Lifesciences Holdings Corp Info
Integra LifeSciences Holdings Corporation is a global medical technology company. The Company manufactures and sells medical technologies and products in two segments: Codman Specialty Surgical (CSS) and Tissue Technologies (TT). The CSS segment consists of technologies and instrumentation used for a range of specialties, such as neurosurgery, neurocritical care and otolaryngology. The CSS business consists of a portfolio of brands, such as Codman, DuraGen, DuraSeal, CUSA, Mayfield, Bactiseal, and Certas Plus, which are used for the management of multiple disease states, including brain tumors, traumatic brain injury, hydrocephalus and other neurological conditions. It provides instruments that are used in precision, specialty and general surgical procedures. The TT segment is focused on three main areas: complex wound surgery, surgical reconstruction and peripheral nerve repair. The TT segment offers skin and wound repair, plastics and surgical reconstruction products, and others.
Ticker SymbolIART
CompanyIntegra Lifesciences Holdings Corp
CEOPoul (Mojdeh)
Websitehttps://www.integralife.com/
Related Instruments
-0.37%
+1.91%
+3.48%
+5.87%
+2.10%
-0.10%
+4.19%
+5.03%
+4.30%
+0.25%
+3.65%
+4.74%
+2.79%
+2.59%
-3.06%
+3.40%
+3.76%
+1.10%
+0.28%
-2.09%Popular Instruments
52852.900
+10.400 (+0.02%)
29669.900
+358.500 (+1.22%)
7507.800
+36.300 (+0.49%)
14963.000
+160.000 (+1.08%)
69676.000
+1528.000 (+2.24%)
6412.400
+59.600 (+0.94%)
68.683
+0.339 (+0.50%)
308.630
+14.250 (+4.84%)
194.830
-2.750 (-1.39%)
4174.610
+52.700 (+1.28%)
FAQs
What is the current price of Integra Lifesciences Holdings Corp (IART)?
The current price of Integra Lifesciences Holdings Corp (IART) is 18.05.
What is the symbol of Integra Lifesciences Holdings Corp?
The ticker symbol of Integra Lifesciences Holdings Corp is IART.
What is the 52-week high of Integra Lifesciences Holdings Corp?
The 52-week high of Integra Lifesciences Holdings Corp is 16.62.
What is the 52-week low of Integra Lifesciences Holdings Corp?
The 52-week low of Integra Lifesciences Holdings Corp is 8.70.
What is the market capitalization of Integra Lifesciences Holdings Corp?
The market capitalization of Integra Lifesciences Holdings Corp is 1.41B.
Is Integra Lifesciences Holdings Corp (IART) currently rated as Buy, Hold, or Sell?
According to analysts, Integra Lifesciences Holdings Corp (IART) has an overall rating of signal_hold, with a price target of 17.20.
What is the Earnings Per Share (EPS TTM) of Integra Lifesciences Holdings Corp (IART)?
The Earnings Per Share (EPS TTM) of Integra Lifesciences Holdings Corp (IART) is -6.74.